{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:34:05Z","timestamp":1791588845451,"version":"4.3.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170551"],"award-info":[{"award-number":["82170551"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10620-025-09176-8","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T14:52:21Z","timestamp":1751727141000},"page":"3323-3339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Faecalibacterium prausnitzii Ameliorates DSS-Induced Colitis via Modulating Bile Acid Metabolism and Regulating FXR Signaling"],"prefix":"10.1007","volume":"70","author":[{"given":"Pingnan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saifei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,5]]},"reference":[{"key":"9176_CR1","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1056\/NEJMra2002697","volume":"383","author":"JT Chang","year":"2020","unstructured":"Chang JT, Longo DL. Pathophysiology of inflammatory bowel diseases. New Engl J Med. 2020;383:2652\u20132664.","journal-title":"New Engl J Med."},{"key":"9176_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","volume":"18","author":"GG Kaplan","year":"2020","unstructured":"Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020;18:56\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"9176_CR3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41575-022-00658-y","volume":"19","author":"TE Adolph","year":"2022","unstructured":"Adolph TE, Meyer M, Schw\u00e4rzler J, Mayr L, Grabherr F, Tilg H. The metabolic nature of inflammatory bowel diseases. Nat Rev Gastroenterol Hepatol 2022;19:753\u2013767.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"9176_CR4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1053\/j.gastro.2020.09.056","volume":"160","author":"M Lee","year":"2021","unstructured":"Lee M, Chang EB. Inflammatory bowel diseases (IBD) and the microbiome-searching the crime scene for clues. Gastroenterology 2021;160:524\u2013537.","journal-title":"Gastroenterology"},{"key":"9176_CR5","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1056\/NEJMra1907607","volume":"385","author":"DC Baumgart","year":"2021","unstructured":"Baumgart DC, Ingelfinger JR, Le Berre C. Newer biologic and small-molecule therapies for inflammatory bowel disease. New Engl J Med 2021;385:1302\u20131315.","journal-title":"New Engl J Med"},{"key":"9176_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.molmed.2023.01.001","volume":"29","author":"NG Kotla","year":"2023","unstructured":"Kotla NG, Rochev Y. IBD disease-modifying therapies: insights from emerging therapeutics. Trends Mol Med 2023;29:241\u2013253.","journal-title":"Trends Mol Med"},{"key":"9176_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","volume":"17","author":"A Lavelle","year":"2020","unstructured":"Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2020;17:223\u2013237.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"9176_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaci.2019.11.003","volume":"145","author":"KL Glassner","year":"2020","unstructured":"Glassner KL, Abraham BP, Quigley EMM. The microbiome and inflammatory bowel disease. J Allergy and Clinical Immunol 2020;145:16\u201327.","journal-title":"J Allergy and Clinical Immunol"},{"key":"9176_CR9","doi-asserted-by":"publisher","first-page":"101210","DOI":"10.1016\/j.plipres.2022.101210","volume":"89","author":"S Lin","year":"2023","unstructured":"Lin S, Wang S, Wang P et al. Bile acids and their receptors in regulation of gut health and diseases. Prog Lipid Res 2023;89:101210.","journal-title":"Prog Lipid Res"},{"key":"9176_CR10","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price J, Arze C, Ananthakrishnan AN et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 2019;569:655\u2013662.","journal-title":"Nature"},{"key":"9176_CR11","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1053\/j.gastro.2018.08.022","volume":"155","author":"ES Friedman","year":"2018","unstructured":"Friedman ES, Li Y, Shen TD et al. FXR-Dependent modulation of the human small intestinal microbiome by the bile acid derivative obeticholic acid. Gastroenterology 2018;155:1741\u20131752.","journal-title":"Gastroenterology"},{"key":"9176_CR12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.chom.2020.01.021","volume":"27","author":"SR Sinha","year":"2020","unstructured":"Sinha SR, Haileselassie Y, Nguyen LP et al. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe 2020;27:659\u2013670.","journal-title":"Cell Host Microbe"},{"key":"9176_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/gut.2010.212159","volume":"60","author":"RM Gadaleta","year":"2011","unstructured":"Gadaleta RM, van Erpecum KJ, Oldenburg B et al. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut 2011;60:463\u2013472.","journal-title":"Gut"},{"key":"9176_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.pharmthera.2018.06.009","volume":"191","author":"V Massafra","year":"2018","unstructured":"Massafra V, Pellicciari R, Gioiello A, van Mil SWC. Progress and challenges of selective Farnesoid X Receptor modulation. Pharmacol Therapeutics 2018;191:162\u2013177.","journal-title":"Pharmacol Therapeutics"},{"key":"9176_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","volume":"5","author":"L Ding","year":"2015","unstructured":"Ding L, Yang L, Wang Z, Huang W. Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharmaceutica Sinica B 2015;5:135\u2013144.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"9176_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/femsre\/fuad039","volume":"47","author":"R Mart\u00edn","year":"2023","unstructured":"Mart\u00edn R, Rios-Covian D, Huillet E et al. Faecalibacterium: a bacterial genus with promising human health applications. FEMS Microbiol Rev 2023;47:4.","journal-title":"FEMS Microbiol Rev"},{"key":"9176_CR17","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1093\/ibd\/izy182","volume":"24","author":"L Zhou","year":"2018","unstructured":"Zhou L, Zhang M, Wang Y et al. Faecalibacterium prausnitzii produces butyrate to maintain Th17\/treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1. Inflamm Bowel Dis 2018;24:1926\u20131940.","journal-title":"Inflamm Bowel Dis"},{"key":"9176_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/gutjnl-2014-307649","volume":"65","author":"E Qu\u00e9vrain","year":"2016","unstructured":"Qu\u00e9vrain E, Maubert MA, Michon C et al. Identification of an anti-inflammatory protein fromFaecalibacterium prausnitzii, a commensal bacterium deficient in Crohn\u2019s disease. Gut. 2016;65:415\u2013425.","journal-title":"Gut."},{"key":"9176_CR19","doi-asserted-by":"publisher","first-page":"107277","DOI":"10.1016\/j.phrs.2024.107277","volume":"206","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li L, Chen S et al. Faecalibacterium prausnitzii-derived extracellular vesicles alleviate chronic colitis-related intestinal fibrosis by macrophage metabolic reprogramming. Pharmacol Res 2024;206:107277.","journal-title":"Pharmacol Res"},{"key":"9176_CR20","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1136\/gutjnl-2023-329964","volume":"72","author":"MF Neurath","year":"2023","unstructured":"Neurath MF, Vieth M. Different levels of healing in inflammatory bowel diseases: mucosal, histological, transmural, barrier and complete healing. Gut 2023;72:2164\u20132183.","journal-title":"Gut"},{"key":"9176_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nri.2017.7","volume":"17","author":"M Levy","year":"2017","unstructured":"Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. Dysbiosis and the immune system. Nat Rev Immunol 2017;17:219\u2013232.","journal-title":"Nat Rev Immunol"},{"key":"9176_CR22","doi-asserted-by":"publisher","first-page":"108238","DOI":"10.1016\/j.pharmthera.2022.108238","volume":"237","author":"J Cai","year":"2022","unstructured":"Cai J, Rimal B, Jiang C, Chiang JY, Patterson AD. Bile acid metabolism and signaling, the microbiota, and metabolic disease. Pharmacol Therapeutics 2022;237:108238.","journal-title":"Pharmacol Therapeutics"},{"key":"9176_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.molmed.2021.12.006","volume":"28","author":"MM Thibaut","year":"2022","unstructured":"Thibaut MM, Bindels LB. Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation. Trends Mol Med 2022;28:223\u2013236.","journal-title":"Trends Mol Med"},{"key":"9176_CR24","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/ismej.2016.176","volume":"11","author":"M Lopez-Siles","year":"2017","unstructured":"Lopez-Siles M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J 2017;11:841\u2013852.","journal-title":"ISME J"},{"key":"9176_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/gutjnl-2024-333530","volume":"74","author":"Z Shi","year":"2025","unstructured":"Shi Z, Li M, Zhang C et al. Butyrate-producing Faecalibacterium prausnitzii suppresses natural killer\/T-cell lymphoma by dampening the JAK-STAT pathway. Gut 2025;74:557\u2013570.","journal-title":"Gut"},{"key":"9176_CR26","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1016\/j.crohns.2013.04.002","volume":"7","author":"X Qiu","year":"2013","unstructured":"Qiu X, Zhang M, Yang X, Hong N, Yu C. Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis. J Crohns Colitis 2013;7:e558-568.","journal-title":"J Crohns Colitis"},{"key":"9176_CR27","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","volume":"63","author":"K Machiels","year":"2014","unstructured":"Machiels K, Joossens M, Sabino J et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 2014;63:1275\u20131283.","journal-title":"Gut"},{"key":"9176_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/intimm\/dxz022","volume":"31","author":"M Zhang","year":"2019","unstructured":"Zhang M, Zhou L, Wang Y et al. Faecalibacterium prausnitzii produces butyrate to decrease c-Myc-related metabolism and Th17 differentiation by inhibiting histone deacetylase 3. Int Immunol 2019;31:499\u2013514.","journal-title":"Int Immunol"},{"key":"9176_CR29","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.3390\/ijms23031705","volume":"23","author":"S Auger","year":"2022","unstructured":"Auger S, Kropp C, Borras-Nogues E et al. Intraspecific diversity of microbial anti-inflammatory molecule (MAM) from Faecalibacterium prausnitzii. Int J Mol Sci 2022;23:1705.","journal-title":"Int J Mol Sci"},{"key":"9176_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fmicb.2017.00114","volume":"8","author":"NM Breyner","year":"2017","unstructured":"Breyner NM, Michon C, de Sousa CS et al. Microbial anti-inflammatory molecule (MAM) from Faecalibacterium prausnitzii shows a protective effect on DNBS and DSS-induced colitis model in mice through inhibition of NF-\u03bab pathway. Front Microbiol 2017;8:114.","journal-title":"Front Microbiol"},{"key":"9176_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12934-023-02243-7","volume":"22","author":"L Ye","year":"2023","unstructured":"Ye L, Wang Y, Xiao F et al. F. prausnitzii-derived extracellular vesicles attenuate experimental colitis by regulating intestinal homeostasis in mice. Microb Cell Factories 2023;22:235.","journal-title":"Microb Cell Factories"},{"key":"9176_CR32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","volume":"14","author":"J Ni","year":"2017","unstructured":"Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol 2017;14:573\u2013584.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"9176_CR33","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/procel\/pwad028","volume":"14","author":"T Wan","year":"2023","unstructured":"Wan T, Wang Y, He K, Zhu S. Microbial sensing in the intestine. Protein Cell 2023;14:824\u2013860.","journal-title":"Protein Cell"},{"key":"9176_CR34","doi-asserted-by":"publisher","first-page":"2265028","DOI":"10.1080\/19490976.2023.2265028","volume":"15","author":"Y Tie","year":"2023","unstructured":"Tie Y, Huang Y, Chen R, Li L, Chen M, Zhang S. Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets. Gut Microbes 2023;15:2265028.","journal-title":"Gut Microbes"},{"key":"9176_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/j.gastro.2023.09.019","volume":"166","author":"A Gilliland","year":"2024","unstructured":"Gilliland A, Chan JJ, De Wolfe TJ, Yang H, Vallance BA. Pathobionts in inflammatory bowel disease: origins, underlying mechanisms, and implications for clinical care. Gastroenterology 2024;166:44\u201358.","journal-title":"Gastroenterology"},{"key":"9176_CR36","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s13238-020-00745-3","volume":"12","author":"S Liu","year":"2021","unstructured":"Liu S, Zhao W, Lan P, Mou X. The microbiome in inflammatory bowel diseases: from pathogenesis to therapy. Protein Cell 2021;12:331\u2013345.","journal-title":"Protein Cell"},{"key":"9176_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","volume":"13","author":"HSP de Souza","year":"2015","unstructured":"de Souza HSP, Fiocchi C. Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol 2015;13:13\u201327.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"9176_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jaci.2022.11.007","volume":"151","author":"JK Tan","year":"2023","unstructured":"Tan JK, Macia L, Mackay CR. Dietary fiber and SCFAs in the regulation of mucosal immunity. J Allergy Clinical Immunol 2023;151:361\u2013370.","journal-title":"J Allergy Clinical Immunol"},{"key":"9176_CR39","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41577-024-01014-8","volume":"24","author":"ER Mann","year":"2024","unstructured":"Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol 2024;24:595.","journal-title":"Nat Rev Immunol"},{"key":"9176_CR40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.immuni.2024.01.002","volume":"57","author":"EM Eshleman","year":"2024","unstructured":"Eshleman EM, Rice T, Potter C et al. Microbiota-derived butyrate restricts tuft cell differentiation via histone deacetylase 3 to modulate intestinal type 2 immunity. Immunity 2024;57:319\u2013332.","journal-title":"Immunity"},{"key":"9176_CR41","doi-asserted-by":"publisher","first-page":"137499","DOI":"10.1016\/j.chemosphere.2022.137499","volume":"313","author":"J Wang","year":"2023","unstructured":"Wang J, Han L, Liu Z et al. Genus unclassified_Muribaculaceae and microbiota-derived butyrate and indole-3-propionic acid are involved in benzene-induced hematopoietic injury in mice. Chemosphere 2023;313:137499.","journal-title":"Chemosphere"},{"key":"9176_CR42","doi-asserted-by":"publisher","first-page":"133993","DOI":"10.1016\/j.foodchem.2022.133993","volume":"399","author":"R Wang","year":"2023","unstructured":"Wang R, Lin F, Ye C et al. Multi-omics analysis reveals therapeutic effects of Bacillus subtilis-fermented Astragalus membranaceus in hyperuricemia via modulation of gut microbiota. Food Chem 2023;399:133993.","journal-title":"Food Chem"},{"key":"9176_CR43","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1136\/gutjnl-2022-328048","volume":"72","author":"A Vich Vila","year":"2023","unstructured":"Vich Vila A, Hu S, Andreu-S\u00e1nchez S et al. Faecal metabolome and its determinants in inflammatory bowel disease. Gut 2023;72:1472\u20131485.","journal-title":"Gut"},{"key":"9176_CR44","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1136\/gutjnl-2023-329969","volume":"73","author":"A Vich Vila","year":"2024","unstructured":"Vich Vila A, Zhang J, Liu M, Faber KN, Weersma RK. Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases. Gut 2024;73:1909\u20131920.","journal-title":"Gut"},{"key":"9176_CR45","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","volume":"62","author":"H Duboc","year":"2013","unstructured":"Duboc H, Rajca S, Rainteau D et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut 2013;62:531\u2013539.","journal-title":"Gut"},{"key":"9176_CR46","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","volume":"21","author":"SL Collins","year":"2023","unstructured":"Collins SL, Stine JG, Bisanz JE, Okafor CD, Patterson AD. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat Rev Microbiol 2023;21:236\u2013247.","journal-title":"Nat Rev Microbiol"},{"key":"9176_CR47","doi-asserted-by":"publisher","first-page":"2356284","DOI":"10.1080\/19490976.2024.2356284","volume":"16","author":"Y Pan","year":"2024","unstructured":"Pan Y, Zhang H, Li M et al. Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis. Gut Microbes 2024;16:2356284.","journal-title":"Gut Microbes"},{"key":"9176_CR48","doi-asserted-by":"publisher","first-page":"2172671","DOI":"10.1080\/19490976.2023.2172671","volume":"15","author":"AB Larabi","year":"2023","unstructured":"Larabi AB, Masson HLP, B\u00e4umler AJ. Bile acids as modulators of gut microbiota composition and function. Gut Microbes 2023;15:2172671.","journal-title":"Gut Microbes"},{"key":"9176_CR49","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"W Jia","year":"2018","unstructured":"Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol 2018;15:111\u2013128.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"9176_CR50","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1053\/j.gastro.2023.02.022","volume":"164","author":"KA Fogelson","year":"2023","unstructured":"Fogelson KA, Dorrestein PC, Zarrinpar A, Knight R. The gut microbial bile acid modulation and its relevance to digestive health and diseases. Gastroenterology 2023;164:1069\u20131085.","journal-title":"Gastroenterology"},{"key":"9176_CR51","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrd2619","volume":"7","author":"C Thomas","year":"2008","unstructured":"Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov 2008;7:678\u2013693.","journal-title":"Nat Rev Drug Discov"},{"key":"9176_CR52","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1016\/j.csbj.2021.04.029","volume":"19","author":"L Jiang","year":"2021","unstructured":"Jiang L, Zhang H, Xiao D, Wei H, Chen Y. Farnesoid X receptor (FXR): structures and ligands. Comput Struct Biotechnol J 2021;19:2148\u20132159.","journal-title":"Comput Struct Biotechnol J"},{"key":"9176_CR53","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.4049\/jimmunol.0803978","volume":"183","author":"P Vavassori","year":"2009","unstructured":"Vavassori P, Mencarelli A, Renga B, Distrutti E, Fiorucci S. The bile acid receptor FXR is a modulator of intestinal innate immunity. J Immunol 2009;183:6251\u20136261.","journal-title":"J Immunol"},{"key":"9176_CR54","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bbadis.2015.11.001","volume":"1862","author":"V Massafra","year":"2016","unstructured":"Massafra V, Ijssennagger N, Plantinga M et al. Splenic dendritic cell involvement in FXR-mediated amelioration of DSS colitis. Biochim Biophys Acta 2016;1862:166\u2013173.","journal-title":"Biochim Biophys Acta"},{"key":"9176_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40168-022-01458-x","volume":"11","author":"Y Pi","year":"2023","unstructured":"Pi Y, Wu Y, Zhang X et al. Gut microbiota-derived ursodeoxycholic acid alleviates low birth weight-induced colonic inflammation by enhancing M2 macrophage polarization. Microbiome 2023;11:19.","journal-title":"Microbiome"},{"key":"9176_CR56","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41385-019-0162-4","volume":"12","author":"ML Chen","year":"2019","unstructured":"Chen ML, Takeda K, Sundrud MS. Emerging roles of bile acids in mucosal immunity and inflammation. Mucosal Immunol 2019;12:851\u2013861.","journal-title":"Mucosal Immunol"},{"key":"9176_CR57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2213041119","volume":"119","author":"T Fu","year":"2022","unstructured":"Fu T, Li Y, Oh TG et al. FXR mediates ILC-intrinsic responses to intestinal inflammation. Proc Natl Acad Sci U S A 2022;119:e2213041119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9176_CR58","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1152\/physrev.00049.2019","volume":"101","author":"A Perino","year":"2021","unstructured":"Perino A, Demagny H, Velazquez-Villegas L, Schoonjans K. Molecular physiology of bile acid signaling in health, disease, and aging. Physiological Rev 2021;101:683\u2013731.","journal-title":"Physiological Rev"},{"key":"9176_CR59","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s10620-020-06715-3","volume":"66","author":"S Fiorucci","year":"2021","unstructured":"Fiorucci S, Carino A, Baldoni M et al. Bile acid signaling in inflammatory bowel diseases. Dig Dis Sci 2021;66:674\u2013693, https:\/\/doi.org\/10.1007\/s10620-020-06715-3","journal-title":"Dig Dis Sci"},{"key":"9176_CR60","doi-asserted-by":"publisher","first-page":"102719","DOI":"10.1016\/j.ebiom.2020.102719","volume":"54","author":"RM Gadaleta","year":"2020","unstructured":"Gadaleta RM, Garcia-Irigoyen O, Cariello M et al. Fibroblast growth factor 19 modulates intestinal microbiota and inflammation in presence of farnesoid X receptor. EBioMedicine 2020;54:102719.","journal-title":"EBioMedicine"},{"key":"9176_CR61","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1053\/j.gastro.2020.05.067","volume":"159","author":"G Sorrentino","year":"2020","unstructured":"Sorrentino G, Perino A, Yildiz E et al. Bile acids signal via TGR5 to activate intestinal stem cells and epithelial regeneration. Gastroenterology 2020;159:956\u2013968.","journal-title":"Gastroenterology"},{"key":"9176_CR62","doi-asserted-by":"publisher","first-page":"117731","DOI":"10.1016\/j.biopha.2024.117731","volume":"181","author":"M Biagioli","year":"2024","unstructured":"Biagioli M, Di Giorgio C, Massa C et al. Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and ROR\u03b3t inverse agonism. Biomed Pharmacother 2024;181:117731.","journal-title":"Biomed Pharmacother"},{"key":"9176_CR63","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.tips.2015.08.002","volume":"36","author":"A Perino","year":"2015","unstructured":"Perino A, Schoonjans K. TGR5 and Immunometabolism: Insights from Physiology and Pharmacology. Trends Pharmacol Sci 2015;36:847\u2013857.","journal-title":"Trends Pharmacol Sci"},{"key":"9176_CR64","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.dld.2013.10.021","volume":"46","author":"H Duboc","year":"2014","unstructured":"Duboc H, Tache Y, Hofmann AF. The bile acid TGR5 membrane receptor: from basic research to clinical application. Dig Liver Dis 2014;46:302\u2013312.","journal-title":"Dig Liver Dis"},{"key":"9176_CR65","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/imm.12045","volume":"139","author":"K Yoneno","year":"2013","unstructured":"Yoneno K, Hisamatsu T, Shimamura K et al. TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn\u2019s disease. Immunology 2013;139:19\u201329.","journal-title":"Immunology"},{"key":"9176_CR66","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","volume":"45","author":"C Guo","year":"2016","unstructured":"Guo C, Xie S, Chi Z et al. Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity 2016;45:802\u2013816.","journal-title":"Immunity"},{"key":"9176_CR67","doi-asserted-by":"publisher","first-page":"101094","DOI":"10.1016\/j.plipres.2021.101094","volume":"82","author":"S Fiorucci","year":"2021","unstructured":"Fiorucci S, Distrutti E, Carino A, Zampella A, Biagioli M. Bile acids and their receptors in metabolic disorders. Prog in Lipid Res 2021;82:101094.","journal-title":"Prog in Lipid Res"},{"key":"9176_CR68","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41586-022-04480-z","volume":"603","author":"D Paik","year":"2022","unstructured":"Paik D, Yao L, Zhang Y et al. Human gut bacteria produce \u03a4\u039717-modulating bile acid metabolites. Nature 2022;603:907\u2013912.","journal-title":"Nature"},{"key":"9176_CR69","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41522-023-00420-5","volume":"9","author":"Y Yan","year":"2023","unstructured":"Yan Y, Lei Y, Qu Y et al. Bacteroides uniformis-induced perturbations in colonic microbiota and bile acid levels inhibit TH17 differentiation and ameliorate colitis developments. NPJ Biofilm Microbio 2023;9:56.","journal-title":"NPJ Biofilm Microbio"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09176-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09176-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09176-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T06:02:39Z","timestamp":1770012159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09176-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":69,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["9176"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09176-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,5]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The animal study was approved by the Ethics and Animal Welfare Committee of Nanjing Drum Tower Hospital (approval number: 2024AE01064).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}